Banque Cantonale Vaudoise Evelo Biosciences, Inc. Transaction History

Banque Cantonale Vaudoise

  • $2.43 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.07 - $12.0 $15,175 - $30,000
-2,500 Closed
0 $0
Q3 2020

Oct 30, 2020
BUY
$3.81 - $5.73 $9,525 - $14,325
2,500 New
2,500 $13,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email